Approved for use through 07/31/2016. OMB 0651-0031
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`SubstItute for form 1449/PTO
`_
`
`Complete if Known
`
`INFORMATION DISCLOSURE
`
`STATEMENT BY APPL'CANT
`(Use as many sheets as necessary)
`
`—14859042
`—009811T:-(2333/5G I——
`
`120m A Fay
`
`Attorney Docket Number
`
`Examiner
`Initials*
`
`Cite
`
`Document Number
`
`Publication Date
`MM-DD-YYYY
`
`Name of Patentee or
`Applicant of Cited Document
`
`Pages, Columns, Lines, Where
`Relevant Passages or Relevant
`Figures Appear
`
`U. S. PATENT DOCUMENTS
`
`Examiner
`Initials*
`
`Foreign Patent Document
`
`FOREIGN PATENT DOCUMENTS
`
`Publication
`Date
`MM-DD-YYYY
`
`Name of Patentee or
`Applicant of Cited Document
`
`Pages, Columns, Lines,
`Where Relevant Passages
`Or Relevant Figures Appear
`
` Examiner
`
`
`
`Examiner
`Initia|s*
`
`Country Codea’NumberATKind Code5 (if known)
`
`'
`.
`
`Include name ofthe author (in CAPITAL LETTERS), title of the article (when appropriate), title of
`the item (book, magazine, journal, serial, symposium, catalog, etc), date, page(s), volume-issue
`number(s), publisher, city and/or country where published.
`
`Co-pending US patent application No. US15/208,537, filed on 07-12-2016.
`
`a
`
`CRIADO et al. Scavenging of photogenerated oxidative species by antimuscarinic drugs:
`atropine and derivatives. Redoc Rep 7(6):385-3-94 (2002).
`
`Signature
`
`Date
`Considered
`
`EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and not
`considered Include copy of this form with next communication to applicant. 1Applicant’s unique citation designation number (optional). 2See Kinds Codes of USPTO
`Patent Documents at y_yyy._._g§_gt_9__g9_y_or MPEP 901. 04. 3Enter Office that issued the document, by the two-letter code (VVIPO Standard ST.3). 4 For Japanese patent
`documents, the indication ofthe year ofthe reign ofthe Emperor must precede the serial number of the patent document. 5Kind of document by the appropriate symbols as
`indicated on the document under WIPO Standard ST.16 if possible. 6Applicant is to place a check mark here if English language Translation is attached.
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the public which is to file (and bythe
`USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 2 hours to complete, including
`gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of
`time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, US. Patent and Trademark Office, PO.
`Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND
`TO: Commissioner for Patents, P.0. Box 1450, Alexandria, VA 2231 3-1 450.
`lfyou need assistance in completing the form, call 1-800-PTO-9199 (1-800-786-9199) and select option 2.
`
`

`

`Approved for use through 07/31/2016. OMB 0651-0031
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`SubstItute for form 1449/PTO
`_
`
`Complete if Known
`
`INFORMATION DISCLOSURE
`
`STATEMENT BY APPL'CANT
`(Use as many sheets as necessary)
`
`—14859042
`—009811T:-(2333/5G I——
`
`120m A Fay
`
`Attorney Docket Number
`
`Examiner
`Initials*
`
`'
`.
`
`004
`
`005
`
`
`
`
`
`NON-PATENT LITERATURE DOCUMENTS
`
`Include name ofthe author (in CAPITAL LETTERS), title of the article (when appropriate), title of
`the item (book, magazine, journal, serial, symposium, catalog, etc.), date, page(s), volume-issue
`number(s), publisher, city and/or country where published.
`
`Guidance for Industry: Q1A (R2) Stability Testing of New Drug Substances and Products. US.
`Department of Health and Human Services, Food and Drug Administration. Retrieved from the
`internet
`
`http://fda.gov/downloads/drugs/guidancecompliancereguIatoryinformation/guideances/ucm0733
`69.pdf (25 pgs.) (November 2013/retrieved 7/27/2016).
`
`PCT/USZO16/34823 International Search Report and Written Opinion dated August 23, 2016.
`
`US. Serial No. 15/208,537 Office Action dated September 30, 2016.
`
`Examiner
`Signature
`
`Date
`Considered
`
`EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and not
`considered Include copy of this form with next communication to applicant. 1Applicant’s unique citation designation number (optional). 2See Kinds Codes of USPTO
`Patent Documents at y_yyy._._u_r_;_gt_9_._g_9_y_0r MPEP 901. 04. 3Enter Office that issued the document, by the two-letter code (VVIPO Standard ST.3). 4 For Japanese patent
`documents, the indication ofthe year ofthe reign ofthe Emperor must precede the serial number of the patent document. 5Kind of document by the appropriate symbols as
`indicated on the document under WIPO Standard ST.16 if possible. 6Applicant is to place a check mark here if English language Translation is attached.
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the public which is to file (and bythe
`USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 2 hours to complete, including
`gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of
`time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, US. Patent and Trademark Office, PO.
`Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND
`TO: Commissioner for Patents, P.0. Box 1450, Alexandria, VA 2231 3-1 450.
`lfyou need assistance in completing the form, call 1-800-PTO-9199 (1-800-786-9199) and select option 2.
`
`